A stylized computer rendering of a human heart and heartbeat.

Early cardiac amyloidosis remains bad news without treatment

For asymptomatic patients diagnosed with amyloid transthyretin cardiomyopathy (ATTR-CM) at an early stage, it may take a few years to progress to clinical heart failure or other cardiovascular complications, according to a longitudinal cohort study that also found that early treatment was associated with greater survival. The retrospective study followed the natural history and prognosis …

Early cardiac amyloidosis remains bad news without treatment Read More »